Beximco Pharmaceutical saw a 12.3% jump in sales to BDT25.6bn ($302m) for its financial year ended 30 June 2020, up from BDT22.8bn reported in 2019. While the Dhaka-based company saw double-digit growth in domestic sales on the back of new launches in the home market, it also expanded its international presence by increasing its export sales and entering new markets. Operating profit was up by more than a tenth to BDT5.6bn.
Nazmul Hassan, managing director at Beximco commented that “despite facing unprecedented operational and logistical challenges as a direct result of...
